ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPONSORED PUBLICATIONS

OPIS

COMPASS Innovative web-platform developed by OPIS to manage Compassionate Use Programmes

Compassionate use is a treatment option that allows the use of an unauthorised medicine. more ➔

20161130-pressrelease-pharmatio.jpg

Performance in Clinical Trials: Pharmatio GmbH with new Portfolio

Pharmatio GmbH, already established in the monitoring and site liaison of clinical trials, has restructured its services. With Clinical Trial Liaison, the sponsors of clinical trials can ensure the patient … more ➔

ADVERTISEMENT

DROOMS - Whitepaper

14 Must-Haves to Boost the Efficiency of Your Data Room

Stop wasting time with data room software that doesn’t really improve your workflow. more ➔

The Jackson Laboratory

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies. more ➔

RightsDirect

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

How Content Access and Manual Process Hinder Mining Efforts more ➔

ADVERTISEMENT

placeholder

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 21 of 21«‹192021

LATEST NEWS

© Zealand Pharma

Zealand pays Chinese OTR US$30m upfront to expand o...

Eli Lilly Corporate Center, IndianapolisMomoneymoproblemz - wikimedia

Lilly‘s retatrutide delivers record weight loss

San Antonio Breast Cancer SymposiumSan Antonio Breast Cancer Symposium

Pfizer presents data for Tukysa in HER2-positive br...

ADVERTISEMENT

MAGAZINE

1 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

2 / 4
EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

3 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

4 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

SPONSORED PUBLICATION

Target_Validation_Hood (Neue Größe 1)
Oncology Research

Tiny Models, Big Impact

Organoids are reshaping cancer R&D by providing more accurate, patient-relevant models than classical methods. By bridging the gap between preclinical and early clinical stages, they enable patient-centric … more ➔

newsletter_link
© BIOCOM Interrelations GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top